Phase I study of oral S-1 plus Gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer
Phase of Trial: Phase I
Latest Information Update: 12 May 2016
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 06 Nov 2012 Planned End Date (31 Dec 2012) added as reported by University Hospital Medical Information Network - Japan record.
- 07 May 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan
- 18 Nov 2008 New trial record.